Top Markets
#1 Akedo Akedo +64.36%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.34%
#4 Cross Cross +45.41%
#5 Black Phoenix Black Phoenix +34.24%
#6 Velvet Velvet +30.05%
#7 OVERTAKE OVERTAKE +26.38%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.75%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.03%
#10 Palladium Network Palladium Network +12.84%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Classement en actions #38693
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Prix de l'action
$0.0601
Capitalisation boursière
$699.79K
Changement (1 jour)
-14.14%
Changement (1 an)
0.17%
Pays
US
Échange Hepion Pharmaceuticals, Inc. (HEPA)

Catégorie

Healthcare
Le prix HEPA avec la capitalisation boursière de B
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
HEPA
$0.0601
Capitalisation boursière de Hepion Pharmaceuticals, Inc.(HEPA)
Capitalisation boursière: $699.79K
En August 2026, Hepion Pharmaceuticals, Inc. a une capitalisation boursière de $699.79K. Cela fait de Hepion Pharmaceuticals, Inc. la 38693rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Hepion Pharmaceuticals, Inc. du 2014 au 2026
HEPA par rapport au top 5 des plus populaires stocks
Prix pour HEPA L’actif B La capitalisation boursière de B Résultats
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$467,541 $699.79K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.444T +777,938,337.35%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$385,092 $699.79K
Apple Inc. Apple Inc.
AAPL
$4.484T +640,752,457.43%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$357,833 $699.79K
Alphabet Inc. Alphabet Inc.
GOOG
$4.166T +595,395,099.18%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$317,784 $699.79K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +528,759,200.49%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$243,787 $699.79K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.839T +405,635,281.29%